title: Impact of blood transfusions and HLA on cyclosporine-treated renal transplant recipients.
authors.affiliation: Department of Surgery, University of Texas Medical School, Houston 77030.
authors.forename: R H
authors.initials: RH
authors.lastname: Kerman
authors.forename: C T
authors.initials: CT
authors.lastname: Van Buren
authors.forename: R M
authors.initials: RM
authors.lastname: Lewis
authors.forename: B D
authors.initials: BD
authors.lastname: Kahan
mesh_terms: D001379:Azathioprine / Q000627:therapeutic use; D001803:Blood Transfusion; D002102:Cadaver; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000627:therapeutic use*; D006085:Graft Survival; D006680:HLA Antigens / Q000276:immunology*; D006681:HLA-D Antigens / Q000276:immunology*; D006684:HLA-DR Antigens / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007518:Isoantibodies / Q000276:immunology; D016030:Kidney Transplantation; D011241:Prednisone / Q000627:therapeutic use; D012307:Risk Factors
chemical_list: D003524:Cyclosporins; D006680:HLA Antigens; D006681:HLA-D Antigens; D006684:HLA-DR Antigens; D007518:Isoantibodies; D003404:Creatinine; D001379:Azathioprine; D011241:Prednisone